Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Khapzory. Always confirm against the full prescribing information.
20 interactions
Colestipol
The serum concentration of Levoleucovorin can be decreased when it is combined with Colestipol.
Level 1 evidence
Dapsone
The therapeutic efficacy of Dapsone can be decreased when used in combination with Levoleucovorin.
Level 2 evidence
Fosphenytoin
The serum concentration of Fosphenytoin can be decreased when it is combined with Levoleucovorin.
Level 1 evidence
Glucarpidase
The serum concentration of the active metabolites of Levoleucovorin can be reduced when Levoleucovorin is used in combination with Glucarpidase resulting in a loss in efficacy.
Level 1 evidence
Methotrexate
The therapeutic efficacy of Methotrexate can be decreased when used in combination with Levoleucovorin.
Level 2 evidence
Pafolacianine
Levoleucovorin may decrease effectiveness of Pafolacianine as a diagnostic agent.
Level 1 evidence
Pemetrexed
The therapeutic efficacy of Pemetrexed can be decreased when used in combination with Levoleucovorin.
Level 2 evidence
Phenobarbital
The serum concentration of Phenobarbital can be decreased when it is combined with Levoleucovorin.
Level 2 evidence
Phenytoin
The serum concentration of Phenytoin can be decreased when it is combined with Levoleucovorin.
Level 1 evidence
Pralatrexate
The therapeutic efficacy of Pralatrexate can be decreased when used in combination with Levoleucovorin.
Level 2 evidence
Primidone
The serum concentration of Primidone can be decreased when it is combined with Levoleucovorin.
Level 1 evidence
Proguanil
The therapeutic efficacy of Proguanil can be decreased when used in combination with Levoleucovorin.
Level 2 evidence
Enter your NPI to unlock 3 major interactions for Khapzory
Khapzory (Levoleucovorin) has 20 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Khapzory (Levoleucovorin) has 3 major, 14 moderate, and 3 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Khapzory. Always confirm against the full prescribing information.